Patents by Inventor Philippe Cartier

Philippe Cartier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040001887
    Abstract: A bioadhesive controlled, extended release progressive hydration composition wherein the active ingredient may be protected from water or the surrounding environment, thereby protecting it from metabolism or from other degradation caused by moisture, enzymes, or pH effects, and making it bioavailable only at a controlled rate. The active ingredient may be protected from moisture during the manufacturing process, as necessary or desired, and more importantly may be protected from moisture and the immediate septic environment until well after the patient has applied the composition, and then only at a slow and controlled rate. It is by this process of progressive hydration that the active ingredient remains protected for many hours after administration. It is also by the process of progressive hydration that controlled and sustained release is achieved because only that part of the active ingredient that is the hydrated (aqueous) fraction of the composition is available for absorption (bioavailable).
    Type: Application
    Filed: April 24, 2003
    Publication date: January 1, 2004
    Inventors: Howard L. Levine, William J. Bologna, Philippe Cartier, Dominique De Ziegler
  • Patent number: 6248358
    Abstract: A bioadhesive tablet wherein the active ingredient may be protected from water or the surrounding environment, thereby protecting it from metabolism or from other degradation caused by moisture, enzymes, or pH effects, and making it bioavailable only at a controlled rate. The active ingredient may be protected from moisture during the manufacturing process and more importantly may be protected from moisture and the immediate septic environment until after the patient has applied the tablet, and then only at a slow and controlled rate. It is by this process of progressive hydration that the active ingredient remains protected for many hours after administration. It is also by the process of progressive hydration that controlled and sustained release is achieved because only that part of the active ingredient that is the hydrated (aqueous) fraction of the tablet is available for absorption (bioavailable).
    Type: Grant
    Filed: August 23, 1999
    Date of Patent: June 19, 2001
    Assignee: Columbia Laboratories, Inc.
    Inventors: William J. Bologna, Howard L. Levine, Philippe Cartier, Dominique de Ziegler
  • Patent number: 5312411
    Abstract: A surgical instrument for shaping the distal femur of a patient to receive a unicondylar prosthetic component includes a cutting guide body that carries a pair of cylindrically shaped openings in the guide body, each of the openings having a central longitudinal axis and the respective axes of the openings forming an acute angle. An annular bushing is removably received in a selected one of the cylindrical openings during a cutting of the distal femur. A bone cutting reamer registers with a central cylindrical opening in the bushing. The bone cutting reamer has an annular shoulder that abuts the top of the bushing to define the depth of cut. During use, the surgeon positions the cutting guide body over a diseased condyle of the patient's distal femur. The surgeon then sequentially places the bushing and its associated bone cutting reamer into one of the selected openings of the cutting guide body.
    Type: Grant
    Filed: October 27, 1992
    Date of Patent: May 17, 1994
    Assignee: Smith & Nephew Richards, Inc.
    Inventors: John K. Steele, Thomas A. Carls, David L. Evans, Carol D. Taylor, Philippe Cartier, James Andrews, William Kennedy